We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Adrenal tumors in patients with neuroendocrine neoplasms

    Purpose

    To study the prevalence of primary adrenal tumors and adrenal metastases in patients with neuroendocrine neoplasms (NENs) and describe these...

    Henrik Falhammar, Adam Stenman, ... Anna Kistner in Endocrine
    Article Open access 06 April 2024
  2. Management of Gastric Neuroendocrine Tumors: A Review

    Gastric neuroendocrine tumors (G-NET) are rare tumors arising from enterochromaffin-like cells of the gastric mucosa. They belong to a larger group...

    Caitlin Sok, Pranay S. Ajay, ... Mihir M. Shah in Annals of Surgical Oncology
    Article 07 December 2023
  3. Cauda equina neuroendocrine tumors show biological features distinct from other paragangliomas and visceral neuroendocrine tumors

    Cauda equina neuroendocrine tumors (CENETs) are neoplasms of uncertain histogenesis with overlap** features between those of paragangliomas (PGs)...

    Jiri Soukup, Monika Manethova, ... Tomas Cesak in Virchows Archiv
    Article 08 November 2022
  4. The Clinicopathological Significance of Tumor Cell Subty** in Appendiceal Neuroendocrine Tumors: A Series of 135 Tumors

    Appendiceal neuroendocrine tumors (NETs) are common and often are identified as incidental lesions at the time of appendectomy. The guidelines for...

    Ozgur Mete, David W. Dodington, ... Sylvia L. Asa in Endocrine Pathology
    Article Open access 04 June 2024
  5. Systemic Therapy for Pancreatic Neuroendocrine Tumors

    Pancreatic neuroendocrine tumors (PanNETs) account for approximately 2% of all pancreatic malignancies. Several systemic treatment options have been...

    Viraj Lavingia, Shruti Gohel, Bhawna Sirohi in Indian Journal of Surgical Oncology
    Article 02 March 2024
  6. Immunoreactivity of HOXB13 in Neuroendocrine Neoplasms Is a Sensitive and Specific Marker of Rectal Well-Differentiated Neuroendocrine Tumors

    HoxB13 is a transcription factor involved in defining of posterior endodermal derivatives, including prostate and rectum. While it is used as a...

    Jiri Soukup, Monika Manethova, ... Filip Gabalec in Endocrine Pathology
    Article 08 August 2023
  7. Two cases of dermatomyositis associated with neuroendocrine tumors

    Dermatomyositis is an idiopathic inflammatory myopathy with cutaneous manifestations, which is associated with several types of malignancies, yet it...

    Uria Shani, Noy Lavine, ... Howard Amital in International Cancer Conference Journal
    Article 31 August 2023
  8. Neuroendocrine and undifferentiated sinonasal and skull base tumors: An up-to-date narrative review

    Tumors located in the nasal cavity, paranasal sinuses and the skull base comprise a wide range of histologic subtypes. Among them, neuroendocrine and...

    Giorgos Sideris, Panagiotis Solomos, ... Alexander Delides in Oral and Maxillofacial Surgery
    Article 19 March 2024
  9. Recent progress of experimental model in pancreatic neuroendocrine tumors: drawbacks and challenges

    The neuroendocrine neoplasm, in general, refers to a heterogeneous group of all tumors originating from peptidergic neurons and neuroendocrine cells....

    Yan Wang, Fei Wang, ... Shunrong Ji in Endocrine
    Article 17 January 2023
  10. Gastrointestinal Neuroendocrine Tumors—Case Series from a Tertiary Care Center with Review of Literature

    Neuroendocrine tumors account for 0.5% of all malignancies, and their incidence is around 2/100,000 with a female predilection within the age range...

    Y.C.S Rekha, B. Sriharsha, ... T. G. Vivek in Indian Journal of Surgical Oncology
    Article 04 July 2024
  11. Risk Factor Analysis of Lymph Node Metastasis for Rectal Neuroendocrine Tumors: Who Needs a Radical Resection in Rectal Neuroendocrine Tumors Sized 1–2 cm?

    Background

    Rectal neuroendocrine tumors (NETs) have malignant potential, and lymph node (LN) or distant metastases can occur; however, treatment of...

    ** Sun Choi, Min Jung Kim, ... Seung-Bum Ryoo in Annals of Surgical Oncology
    Article 09 January 2024
  12. Epidemiology of gastroenteropancreatic neuroendocrine neoplasms: a review and protocol presentation for bridging tumor registry data with the Italian association for neuroendocrine tumors (Itanet) national database

    Abstract

    Neuroendocrine neoplasms (NENs) are rare tumors with diverse clinical behaviors. Large databases like the Surveillance, Epidemiology, and End...

    Francesco Panzuto, Stefano Partelli, ... Massimo Falconi in Endocrine
    Article Open access 04 January 2024
  13. Efficacy and tolerability of somatostatin analogues according to gender in patients with neuroendocrine tumors

    As the incidence of neuroendocrine tumors has been rising, gender differences in epidemiology and clinical behavior have emerged, and interest into a...

    Rosaria M. Ruggeri, Irene Aini, ... Antongiulio Faggiano in Reviews in Endocrine and Metabolic Disorders
    Article 05 December 2023
  14. Analysis of 25 surgical cases of thymic neuroendocrine tumors and thymic carcinoma

    Background

    The purpose of this study was to evaluate the clinicopathological characteristics of patients who underwent surgical resection for thymic...

    Kensuke Midorikawa, So Miyahara, ... Toshihiko Sato in Journal of Cardiothoracic Surgery
    Article Open access 16 April 2024
  15. Long-Term Oncologic Outcome following Duodenum-Preserving Pancreatic Head Resection for Benign Tumors, Cystic Neoplasms, and Neuroendocrine Tumors: Systematic Review and Meta-analysis

    Background

    Pancreatoduodenectomy (PD) has a considerable surgical risk for complications and late metabolic morbidity. Parenchyma-sparing resection of...

    Hans G. Beger, Benjamin Mayer, Bertram Poch in Annals of Surgical Oncology
    Article Open access 05 April 2024
  16. Lost in translation: evaluating the readability of online patient information for neuroendocrine tumors

    Introduction

    Recent data show that many patients with NETs do not receive sufficient education regarding their diagnosis and therefore tend to search...

    Alexander Paschke, Udhayvir Singh Grewal in Endocrine
    Article 27 November 2023
  17. Prospective study on stereotactic body radiotherapy for small pancreatic neuroendocrine tumors: tolerance and effectiveness analysis

    Introduction

    Surgery is the standard treatment for pancreatic neuroendocrine tumors (pNETs), obtaining favorable results but associating high...

    Mercedes López Gonzalez, Ovidio Hernando-Requejo, ... Carmen Rubio in Clinical and Translational Oncology
    Article 22 June 2024
  18. An Update on Appendiceal Neuroendocrine Tumors

    The mainstay of appendiceal neuroendocrine neoplasm (aNEN) treatment is surgery, based on simple appendectomy or right-sided hemicolectomy with...

    Elisa Andrini, Giuseppe Lamberti, ... Davide Campana in Current Treatment Options in Oncology
    Article Open access 04 May 2023
  19. Co-existing Neuroendocrine Tumors in the Ileum and Pancreas: A Clinico-Pathological Challenge

    Ileal (I) and pancreatic (Pan) neuroendocrine tumors (NETs) are among the most common digestive neuroendocrine neoplasms (NENs). Coexisting NETs at...

    Alice Laffi, Alexia Francesca Bertuzzi, ... Silvia Uccella in Endocrine Pathology
    Article 07 June 2024
  20. Impact of Regional Metastasis on Survival for Patients with Nonfunctional Pancreatic Neuroendocrine Tumors: A Systematic Review

    Background

    Controversy exists regarding the benefit of lymphadenectomy for nonfunctional pancreatic neuroendocrine tumors (NF-PNET).

    Patients and...
    Callisia N. Clarke, Erin Ward, ... Doug B. Evans in Annals of Surgical Oncology
    Article 23 April 2024
Did you find what you were looking for? Share feedback.